azasetron has been researched along with Anticipatory Vomiting in 3 studies
azasetron: a selective 5-HT3 receptor antagonist; structure given in first source;
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized crossover study between azasetron alone and azasetron combined with dexamethasone was performed to investigate the prevention of nausea and vomiting due to chemotherapy including cisplatin in patients with advanced head and neck carcinoma." | 9.09 | [A randomized crossover comparison of azasetron alone and azasetron plus dexamethasone for the prevention of nausea and vomiting by chemotherapy including cisplatin]. ( Arai, Y; Enomoto, H; Fujii, M; Inaba, H; Kanke, M; Kawai, S; Taguchi, T; Tsukuda, M, 2000) |
| "A randomized crossover study between azasetron alone and azasetron combined with dexamethasone was performed to investigate the prevention of nausea and vomiting due to chemotherapy including cisplatin in patients with advanced head and neck carcinoma." | 5.09 | [A randomized crossover comparison of azasetron alone and azasetron plus dexamethasone for the prevention of nausea and vomiting by chemotherapy including cisplatin]. ( Arai, Y; Enomoto, H; Fujii, M; Inaba, H; Kanke, M; Kawai, S; Taguchi, T; Tsukuda, M, 2000) |
| "Azasetron (Serotone) is a potent and selective 5-HT3 receptor antagonist, and classified as benzamide derivative." | 1.30 | [Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist]. ( Tsukagoshi, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, T | 1 |
| Sato, M | 1 |
| Konaka, M | 1 |
| Makino, A | 1 |
| Hirohata, T | 1 |
| Totsu, S | 1 |
| Wada, Y | 1 |
| Sato, H | 1 |
| Inotsume, N | 1 |
| Fujita, A | 1 |
| Sekine, K | 1 |
| Tsukagoshi, S | 1 |
| Fujii, M | 1 |
| Kanke, M | 1 |
| Arai, Y | 1 |
| Kawai, S | 1 |
| Enomoto, H | 1 |
| Inaba, H | 1 |
| Taguchi, T | 1 |
| Tsukuda, M | 1 |
1 trial available for azasetron and Anticipatory Vomiting
| Article | Year |
|---|---|
[A randomized crossover comparison of azasetron alone and azasetron plus dexamethasone for the prevention of nausea and vomiting by chemotherapy including cisplatin].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; | 2000 |
2 other studies available for azasetron and Anticipatory Vomiting
| Article | Year |
|---|---|
[Comparison of ramosetron and azasetron for prevention of acute and delayed cisplatin-induced emesis in lung cancer patients].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bi | 2006 |
[Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist].
Topics: Administration, Oral; Antiemetics; Biological Availability; Bridged Bicyclo Compounds, Heterocyclic; | 1999 |